Diamyd Medical develops therapies for type 1 diabetes|Anders EssenMoller,Chairman,Diamyd Medical 00:10:00

Share On Facebook Share On Twitter

Born in 1941. M.Sc. Founder of and CEO during 1996-2007 of Diamyd Medical and Chairman 2007 –2015. Independent of the Company, major owner. Founder of Synectics Medical AB, sold to Medtronic, Inc. in 1996. Chairman of NextCell Pharma AB.

Recent Videos